Here’s a brief overview of Scanfil from Carnegie.
Scanfil is expected to report a Q4/2024 sales decrease of minus five percent, which would be an improvement from Q3’s -19 percent.
The acquisition of SRX Global supports growth, even though organic growth remains negative. Stable demand and efficiency measures contribute to an adjusted EBIT margin of 7.1 percent.
Share price: EUR8.3
Fair value range: EUR8.8–10.6